Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DNC008342

Drug Information
IndicationNot AvailableExperimental    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)
TargetHeat shock protein beta-1Inhibitor[1]
MAP kinase p38 alphaInhibitor[2]
MAP kinase p38 betaInhibitor[3]
MAP kinase p38 gammaInhibitor[3]
Serine/threonine-protein kinase B-rafInhibitor[2]
Serine/threonine-protein kinase RAFInhibitor[3]
Tyrosine-protein kinase LCKInhibitor[3]
c-Jun N-terminal kinase 2Inhibitor[3]
Ref 1Bioorg Med Chem Lett. 2008 Aug 1;18(15):4433-7. Epub 2008 Jun 12.Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes. To Reference
Ref 2Bioorg Med Chem. 2010 Aug 1;18(15):5738-48. Epub 2010 Jun 4.The design, synthesis, and evaluation of 8 hybrid DFG-out allosteric kinase inhibitors: a structural analysis of the binding interactions of Gleevec, Nexavar, and BIRB-796. To Reference
Ref 3J Med Chem. 2008 Jul 24;51(14):4122-49. Epub 2008 Jun 26.Design, synthesis, and biological evaluation of novel Tri- and tetrasubstituted imidazoles as highly potent and specific ATP-mimetic inhibitors of p38 MAP kinase: focus on optimized interactions with the enzyme's surface-exposed front region. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543